US equities |
SPCX $167.01 ▲+5.06% NVDA $237.25 ▲+1.41% MU $1,065.18 ▼-0.90% TSLA $377.75 ▲+1.93% MSFT $525.26 ▲+1.49% INTC $116.48 ▼-2.39% SNDK $1,712.65 ▼-0.43% META $745.88 ▲+2.44%
FinancialContent

Articles published by Iterum Therapeutics plc

News headline image
Iterum Therapeutics Reports Employment Inducement Grant
From Iterum Therapeutics plc
Via GlobeNewswire
Tickers ITRM
News headline image
Iterum Therapeutics announces Issuance of Allowance for a U.S. Patent Covering Oral Sulopenem
From Iterum Therapeutics plc
Via GlobeNewswire
Tickers ITRM
News headline image
Iterum Therapeutics Reports Third Quarter 2022 Financial Results
From Iterum Therapeutics plc
Via GlobeNewswire
Tickers ITRM
News headline image
Iterum Therapeutics to Provide Business Update and Report Third Quarter 2022 Financial Results on November 10, 2022
From Iterum Therapeutics plc
Via GlobeNewswire
Tickers ITRM
News headline image
Iterum Announces First Patient Dosed in REASSURE, a Phase 3 Clinical Trial of Oral Sulopenem in Uncomplicated Urinary Tract Infections
From Iterum Therapeutics plc
Via GlobeNewswire
Tickers ITRM
News headline image
Iterum Therapeutics to Present Data at IDWeek 2022
From Iterum Therapeutics plc
Via GlobeNewswire
Tickers ITRM